Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.
You can purchase shares of Foghorn Therapeutics (NASDAQ:FHTX) through any online brokerage.
Other companies in Foghorn Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR), Larimar Therapeutics (NASDAQ:LRMR), Tevogen Bio Holdings (NASDAQ:TVGN) and Sangamo Therapeutics (NASDAQ:SGMO).
Foghorn Therapeutics has a consensus price target of $14.63.
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $4.08 last updated January 24, 2025 at 7:39 PM EST.
There are no upcoming dividends for Foghorn Therapeutics.
Foghorn Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Foghorn Therapeutics.
Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.